Entering text into the input field will update the search result below

Becerra: Medicare premium increase re-evaluation after Biogen Aduhelm price cut

Jan. 10, 2022 10:28 AM ETBiogen Inc. (BIIB)By: Jonathan Block, SA News Editor1 Comment

Medicare Part B on a desk.

designer491/iStock via Getty Images

  • HHS Secretary Xavier Becerra has ordered a re-evaluation of a planned Medicare premium increased spurred by Biogen's (BIIB +0.5%) Alzheimer's treatment Aduhelm (aducanumab) after the company cut the price in half, the Associated

Recommended For You

Comments (1)

Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

22thoroughbred profile picture
So I got my SSDI payment reduced for 1 product that Medicare doesn’t cover and now they might. Not how a co. does biz.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.